Loading
A phase 3 trial of Pevonedistat and Azacitidine in Leukaemia, run by PETHEMA Foundation, active and no longer recruiting.
Study to Compare Azacitidine Plus Pevonedistat Versus Azacitidine in Patients With Acute Myeloid Leukemia Not Eligible for Standard Chemotherapy is a phase 3 interventional study registered as NCT04090736 by PETHEMA Foundation, with 302 participants planned, started 2019-09-24 and due to reach its primary completion in 2023-06-30. Interventions recorded: Pevonedistat, Azacitidine. Conditions recorded: Leukemia, Myeloid, Acute.
Linked to the drug Pevonedistat because the registry names it among its interventions and Leukaemia among its conditions. Registry record only: no result has been read by an editor.
Shares Pevonedistat, Azacitidine, Leukaemia (all types) and the tag pipeline.
Shares Azacitidine, Leukaemia (all types) and the tag pipeline.
Shares Azacitidine, Leukaemia (all types) and the tag pipeline.
Shares Azacitidine, Leukaemia (all types) and the tag pipeline.
Shares Leukaemia (all types) and the tag pipeline.
Shares Leukaemia (all types) and the tag pipeline.
Shares Azacitidine and the tag pipeline.
Shares Leukaemia (all types) and the tag pipeline.